ARS Pharmaceuticals (SPRY) Accumulated Expenses (2020 - 2026)

ARS Pharmaceuticals (SPRY) posted Accumulated Expenses of $5.8 million for Q1 2026, up 27.66% sequentially from $4.6 million in Q4 2025.

ARS Pharmaceuticals (SPRY) Accumulated Expenses (2020 - 2026) Analysis & Trends

ARS Pharmaceuticals has reported Accumulated Expenses for 6 years, with the latest figure at $5.8 million in Q1 2026.

Quarterly Accumulated Expenses changed N/A year-over-year to $5.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (changed N/A YoY) and the FY2025 annual result came in at $4.6 million, up 146.74% from the prior year.
Accumulated Expenses rose to $5.8 million in Q1 2026 per SPRY's latest filing, from $4.6 million in the prior quarter.
Over five years, Accumulated Expenses peaked at $12.0 million in Q4 2022 and troughed at $404000.0 in Q1 2022.
A 4-year average of $3.7 million and a median of $2.1 million in 2022 frame the typical range for Accumulated Expenses.
The sharpest annual moves came in 2022 and 2025: Accumulated Expenses sank 93.03% in 2022, then jumped 146.74% in 2025.
Over 4 years, Accumulated Expenses stood at $12.0 million in 2022, then slumped by 84.54% to $1.9 million in 2024, then soared by 146.74% to $4.6 million in 2025, then rose by 27.66% to $5.8 million in 2026.
According to Business Quant data, Accumulated Expenses over the past three periods registered $5.8 million, $4.6 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	ARS Pharmaceuticals	561.88 Mn	418.03 Mn	-

Download Data